Has Puja Joshi received payments from drug or device companies?

Yes. Drug and device makers reported $724 in general payments to Puja Joshi across 48 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Puja Joshi did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Puja Joshi come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Puja Joshi

Neurology with Special Qualifications in Child Neurology · Livingston, NJNPI 1811248164

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $451 and has fallen 89.2% since, to $49 in 2023.

$724in general payments, 2019–2025

Across 48 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sunovion Pharmaceuticals Inc.$102
Teva Pharmaceuticals USA, Inc.$84
Novartis$83
Neuropace, Inc.$74
Upsher-smith Laboratories LLC$44
Supernus Pharmaceuticals, Inc.$41
plus $297 from 16 others

What the payments were for

Food & beverage$724100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sunovion Pharmaceuticals Inc.	8	$102
Teva Pharmaceuticals USA, Inc.	6	$84
Novartis	5	$83
Neuropace, Inc.	3	$74
Upsher-smith Laboratories LLC	3	$44
Supernus Pharmaceuticals, Inc.	3	$41
Biodelivery Sciences International, Inc.	2	$41
Eisai Inc.	2	$30
Shire North American Group Inc	2	$29
UCB, Inc.	2	$25
Livanova USA, Inc.	1	$18
AstraZeneca	1	$15
Vertical Pharmaceuticals, LLC	1	$15
Jazz Pharmaceuticals Inc.	1	$15
Ironshore Pharmaceuticals Inc.	1	$15
Mallinckrodt Enterprises LLC	1	$14
Sanofi	1	$14
Tris Pharma Inc	1	$14
Harmony Biosciences LLC	1	$14
Aquestive Therapeutics, Inc.	1	$14
Adlon Therapeutics L.p.	1	$13
Greenwich Biosciences, Inc.	1	$12

How this compares

$724 in reported general payments places this provider in the 65th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.

See all neurology with special qualifications in child neurology providers in New Jersey →

Other neurology with special qualifications in child neurology in Livingston

Aliza AlterLivingston$9K
Juliann PaolicchiHackensack$80K
Trevor DesouzaMorristown$14K
Rao PasupuletiHamilton$11K
Sara RubensteinHackensack$7K
Carlos LastraNew Brunswick$5K
Jacqueline RomeroMarlboro$4K
Sohum TrivediMarlboro$4K
Romana KulikovaGarwood$4K
Rajeshwari MahalinghamNew Brunswick$3K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →